Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 22/04/20111 min de lecture
Implantation or Injectable Dosage Form New Animal Drugs; Enrofloxacin
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Bayer HealthCare LLC. The supplemental NADA provides for the addition of a pathogen to the indications for use of enrofloxacin solution in cattle, as a single injection, for the treatment of respiratory disease.
Langue originale de la source: Federal Register — Health and Human ServicesOuvrir le communiqué original →